transfected into L929 cells using lipofectamine 2000 according to manufacturer's instruction (Invitrogen). Lentiviral vector for STING shRNA was described previously (5) ; the targeting sequence for STING was: 5'-CCTCATCAGTGGAATGGAA (only sense strand sequence is shown). Digitonin permeabilization was used to deliver cGAMP, c-di-GMP, and c-di-AMP into cultured cells as previously described (8) .
The procedures for native gel electrophoresis to detect IRF3 dimerization, SDSpolyacrylamide gel electrophoresis (SDS-PAGE), and Western blotting have been described previously (19) . Reverse transcription and real-time PCR reactions were carried out as described before (3) . Basically, iScript cDNA synthesis kit and iQ SYBR Green Supermix (Bio-Rad) were used according to manufacturer's instructions. Sperandio, UT Southwestern Medical Center) and was inserted into pET-21a vector in which the His 6 tag was fused to the C-terminus of VC0179 protein. BL21/pLys harboring the PFO or VC0179 plasmid was induced with 0.5 mM IPTG at 37°C for 4hr, and the recombinant proteins were purified using Ni-NTA column as described above.
In vitro Assay for STING Activator
To isolate the cellular factor that could activate the STING pathway, L929 cells were transfected with DNA for 4-6 hr and then homogenized by douncing in the hypotonic buffer [10mM Tris-HCl, pH7.4, 10mM KCl, 1.5mM MgCl 2 ]. The homogenate was centrifuged at 100,000 rpm for 20 min, then the supernatant (S100) was heated at 95°C for 5 min and centrifuged again at 12,000 rpm for 5 min to remove denatured proteins. To synthesize the STING activator in a cell-free system, S100 from non-stimulated L929 
cGAMP-STING Binding Assay
32 P-labeled cGAMP was synthesized using [α-32 P]-ATP, GTP, and the bacterial cyclase VC0179 as reported (10) . cGAMP binding to STING was performed as described for the binding between c-di-GMP and STING (9), except that cross-linking was performed in a UV-crosslinker (Stratagene) at 1.0 Joule/cm 2 .
Chemical Synthesis of cGAMP
All reactions were performed in glassware under a positive pressure of argon. The synthesis scheme was modified from reference (20 (0.018 mL, 1.0 mmol, 10 equiv), and a solution of 6% dichloroacetic acid in CH 2 Cl 2 (1.2 mL, 0.88 mmol) was then added. After 10 min, the reaction was quenched by pyridine (0.14 mL, 1.74 mmol). The solution was concentrated and the crude mixture was used directly for next step. 
LC-MS and LC-MS/MS
High resolution LCMS analysis was performed using a Dionex Ultimate 3000 nanoLC Tandem MS/MS analysis was performed on a LTQ-XL mass spectrometer (ThermoFisher Scientific) equipped with a HPLC system (Eksigent NanoLC 2D).
Analytes were eluted using a segmented gradient of 2-70% of eluent B with a constant flow of 200 nl/min in 56 min. The mass spectrometer was operated in data -dependent mode with dynamic exclusion of 30s. Full scan MS spectra were acquired in a mass range from m/z 100 to 1500. The 3 most intense ions were sequentially isolated for CID fragmentation in the linear ion trap to generate MS/MS Spectra.
For targeted quantification of cGAMP, a selective reaction monitoring (SRM) assay was developed on the LTQ XL mass spectrometer. In the assay, three transitions of each target ion were monitored (see Table 1 ). The parent ion was isolated with a mass window of 1.0 m/z units, fragmented (collision energy=35, activation time=30 ms at Q=0.25), while the resulting daughter ion was scanned with a mass window of 1.6 m/z unit. The maximum ion accumulation time was 100ms, and the number of microscans was set to 1. 4-7) . IgG beads were used as a negative control (lanes 2 and 3). Both beads were washed and then boiled in water to elute the heat-resistant small molecule STING activator. The eluted ('bound') and unbound fractions were tested for their ability to stimulate IRF3 in permeabilized THP1 cells. In lanes 8 and 9, the beads containing STING-Flag were not incubated with heat-resistant supernatant and served as a negative control. (C) Purification of the small molecule STING activator by HPLC using a C18 column. The starting materials for this column had been partially purified through three steps as described in A. The inset indicates IRF3 dimerization assays for selected fractions from the C18 column. 
